Pharmaceutical Contract Sales Outsourcing Market Size to Record US$ 14.5 Bn through 2030

SHARE THIS ARTICLE

The global pharmaceutical contract sales outsourcing market size was valued at USD 7.1 billion in 2020 and is expected to reach USD 14.5 billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.

Pharmaceutical Contract Sales Outsourcing Market (By Service: Personal Promotion, Non-personal Promotion, Others; By Therapeutic Area: Oncology, Cardiovascular Disorders, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38524

Increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations, as it offers cost controls, better results, and flexibility in terms of operations is anticipated to drive the global pharmaceutical contract sales outsourcing (CSO) market.

Digitalization of Services Provided by CSOs to Propel Market

Improved and advanced services provided by CSOs such as in the field of non-personal promotions are anticipated to drive the global market during the forecast period. Large as well as small pharmaceutical companies are looking for drugs to cost effectively and quickly enter their pipelines and CSOs play an important role in this endeavor.

The rise in virtual detailing in outsourcing services is increasing dependence on CSO services. The surge in the usage of teledetailng propels the non-personal promotion of outsourcing. These advanced functions, including sales force and customer support are well-established in a CSO, and hence, can help the brand to get market recognition faster.

Key Segments

In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others. The personal promotion segment has been split into promotional sales team, key account management, and vacancy management. The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others

Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others.

Base on region, the North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period. Well-established healthcare, early adoption of technologically advanced services, and increase in acceptance & demand for pharmaceutical contract sales outsourcing services are the major factors likely to drive the market in the region during the forecast period

The market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2030.

Key Players

The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market: Segmentation

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Service

  • Personal Promotion
      • Promotional Sales Team
        • Dedicated Sales Team
        • Syndicated Sales Team
      • Key Account Management
      • Vacancy Management
  • Non-personal Promotion
      • Tele-detailing
      • Interactive E-detailing
      • Customer Service
      • Medical Science Liaisons
      • Patient Engagement Services
      • Others (telesampling)
  • Others (Field Management/Reporting and Sales Training)

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Therapeutic Area

    • Cardiovascular Disorders
    • Oncology
    • Metabolic Disorders
    • Neurology
    • Orthopedic Diseases
    • Infectious Diseases
    • Others

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Region

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
  • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38524 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *